Quick Answer
Mereo BioPharma Group plc reported Total Assets of $45.92 million for fiscal year 2025.
Mereo BioPharma Group plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $45.92M | -39.9% |
| 2024 | $76.39M | +14.9% |
| 2023 | $66.50M | -14.1% |
| 2022 | $77.41M | -38.8% |
| 2021 | $126.42M | +100.8% |
| 2020 | $62.95M | -27.2% |
| 2019 | $86.45M | +28.5% |
| 2018 | $67.28M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $53.60M | -39.6% | -14.4% |
| June 30, 2025 | $62.63M | -34.8% | -8.3% |
| March 31, 2025 | $68.32M | +22.1% | -10.6% |
| December 31, 2024 | $76.39M | +14.9% | -13.9% |
| September 30, 2024 | $88.75M | — | -7.7% |
| June 30, 2024 | $96.13M | — | +71.9% |
| March 31, 2024 | $55.94M | — | -15.9% |
| December 31, 2023 | $66.50M | — | — |
- Mereo BioPharma Group plc showed a decrease of -39.9% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Mereo BioPharma Group plc’s total assets has declined by 31.7% (from $67.28 million to $45.92 million).
- The most recent figure is from Mereo BioPharma Group plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: